![](/img/cover-not-exists.png)
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae
T.R Anderegg, D.J Biedenbach, R.N JonesVolume:
46
Year:
2003
Language:
english
DOI:
10.1016/s0732-8893(03)00039-7
File:
PDF, 51 KB
english, 2003